期刊文献+

罗格列酮对人肾小管上皮细胞转分化的影响

下载PDF
导出
摘要 目的:观察罗格列酮(rosiglitazone,RGZ)对TGF-β1刺激人肾小管上皮细胞转分化的影响。方法:人肾小管上皮细胞(HK-2)经同步培养后分为3组:正常对照组,TGF-β1刺激组,TGF-β1+RGZ组(10μmol/LRGZ)。给予TGF-β1刺激24h后,分别应用WesternBlot和免疫荧光方法检测上皮细胞转分化相关指标的表达变化;应用Transwellassay检测细胞迁移能力。结果:①与正常对照组比较,TGF-β1刺激组细胞呈梭形变,E-钙黏素蛋白表达减弱(P<0.01),波形蛋白、纤维连接蛋白表达增强(P<0.01);细胞的迁移能力亦明显增强。②与TGF-β1刺激组比较,TGF-β1+RGZ组细胞恢复为多边形或圆形,E-钙黏素蛋白表达增加(P<0.01),波形蛋白、纤维连接蛋白表达减弱(P<0.01);细胞的迁移能力亦明显减弱。结论:①TGF-β1刺激后HK-2细胞出现表型转化。②RGZ能够减弱TGF-β1刺激下HK-2细胞的表型转化。
出处 《广西医科大学学报》 CAS 2010年第3期370-373,共4页 Journal of Guangxi Medical University
  • 相关文献

参考文献9

  • 1Kalluri R,Neilson EG.Epithelial-mesenchymal transition and its implications for fibrosis[J].J Clin Invest,2003,112 (12):1 776-1 784.
  • 2Strutz F,Zeisberg M,Ziyadeh FN,et al.Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation[J].Kidney Int,2002,61(5):1 714-1 728.
  • 3Mudaliar S,Henry RR.New oral therapies for type 2 diabetes mellitus:The glitazones or insulin sensitizers[J].Annu Rev Med,2001,52 (1):239-257.
  • 4Yang J,Liu Y.Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis[J].J Am Soc Nephrol,2002,13 (1):96-107.
  • 5Guan YF,Breyer MD.Peroxisome proliferators-activated receptors (PPARs):Novel therapeutic targets in renal disease[J].Kidney Int,2001,60(1):14.
  • 6孟晓青,邓安国,朱忠华,杨晓,刘建设,付玲,朱红艳,王全胜.罗格列酮抑制大鼠肾间质纤维化的实验研究[J].华中科技大学学报(医学版),2004,33(2):150-153. 被引量:6
  • 7林沁,马骥,顾勇,杨海春,朱蔚钰,林善锬.罗格列酮对单侧输尿管梗阻大鼠肾间质纤维化的保护作用及其机制[J].中国临床药学杂志,2003,12(3):135-138. 被引量:17
  • 8Bottinger EP,BitzerM.TGF-β1 signaling in renal disease[J].JAm Soc N ephrol,2002,13(10):2 600-2 610.
  • 9Dai C,Yang J,Liu Y.Transforming growth factor-[beta] 1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling[J].J B-iol Chem,2003,278 (14):12 537-12 545.

二级参考文献21

  • 1[1]Mudaliar S, Henry RR. New oral therapies for type 2 diabetes mellitus:The glitazones or insulin sensitizers[ J ]. Annu Rev Med, 2001,52 ( 1 ):239.
  • 2[2]Kon K, Ikejima K, Hirose M, et al. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride[J]. Biochem Biophys Res Commun, 2002,291 ( 1 ): 55.
  • 3[3]Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activationin vivo and in vitro [ J]. Gastroenterology ,2002,122(7 ): 1924.
  • 4[4]Moriyama T, Kawada N, Nagatoya K, et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction[J]. Kidney Int,2001,59(6) :2095.
  • 5[5]Guan YF, Breyer MD. Peroxisome proliferators-activated receptors(PPARs): Novel therapeutic targets in renal disease[J]. Kidney Int,2001,60( 1 ): 14.
  • 6[6]Iwashima Y, Eto M, Horiuchi S, et al. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells[J]. Biochem Biophys Res Commun, 1999,264(2) :441.
  • 7[7]Asano T, Wakisaka M, Yoshinari M, et al. Peroxisome proliferator-activated receptor gammal (PPARgammal) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation[J]. Biochem Biophys Acta,2000,1497(1 ): 148.
  • 8[8]Jinde K, Nikolic-Paterson DJ, Huang XR, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis[J]. Am J Kidney Dis,2001,38(4) :761.
  • 9[9]Ng YY, Huang TP, Yang WC, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats[J]. Kidney Int, 1998,54(3) :864.
  • 10Asano T, Wakisaka M, Yoshinar M et al. Peroxisome proliferator-activated receptors gamma 1(PPARgamma 1)expresses in rat mesangial cells and PPARgamm agonists nodalate its differentiation. Biochem Biophys Acta,2000,1497:148

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部